Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Im friends with warren Buffett and he would never but pmcb
to bad PMCB is a failure
getting closer everyday
is PMCB still in business?
sounds a lot like kenny
The pre-recorded presentation by PharmaCyte will be available on Monday, January 10, 2022, on the News & Media tab of PharmaCyte’s website at https://PharmaCyte.com/Media.
another lie by kw
is KW the next Elizabeth Holmes?
same people involved in this are involved in PMCB scam
whatever happened to Hidalgo and Iglesius
post link
what ever happen to Hidalgo,judd and Dr Susan
KW must think we forgot that the Von Hoff study was a failure
I love when that happens
from yahoo showing pmcbs year to date
Previous Close 2.5900
Open 2.5700
Bid 2.5400 x 1000
Ask 2.6300 x 1400
Day's Range 2.5000 - 2.6200
52 Week Range 2.2500 - 57.3500
Volume 353,174
Avg. Volume 2,133,214
The CEO is a scammer.God bless all
all facts that can not be disputed by PMCB
it took PMCB 10 years to figure that out when it been known forever
PMCB IND is now inactive
kw always associate himself with the best
Iroquois’ Richard Abbe quits XpresSpa while company battles Fraud Lawsuit
An XpresSpa board member, Richard Abbe of Iroquois Capital, has quit the company board during the middle of a heated legal battle accusing board members of deception, undue influence, and fraud. The day before his resignation Abbe, who is named personally in the lawsuit, took the extra step to retain his own lawyer in the securities fraud lawsuit that I first reported on in August.
Over the holiday break, when no one was paying attention to SEC filings, XpresSpa filed an 8-K on December 26th announcing Abbe’s departure as of December 18. Then after years of board service XpresSpa suddenly decided they should vote to offer the hedge fund manage a holiday gift. The board agreed to indemnify Abbe and advance any legal fees he might need to defend his good name from allegedly being involved with shenanigans, like you know misleading regulators or stock holders. The 8-K says this nice little exit present also includes the company picking up the tab for any fines or settlements Abbe might have to pay as a result of his work on the board. But what’s not clear is if Abbe was found acting in bad faith or criminal conduct that the indemnity would still hold.
The defendants in this case are being accused of a fraudulent scheme to trick the founders of an airport spa business, XpresSpa, into a merger with a public Microcap company that resulted in a massive loss of their business investment.The public company was called Form Holdings.
During the litigation, that begin in November 2017, I reported an ex-wife came forward with some potentially damaging evidence that would put some of the defendants in the hot seat with the Securities and Exchange Commission. That’s because the Sarbanes Oxley Act upped the anti for individuals to be charged criminally for making false claims in a Proxy Statement. A proxy statement is a legal document containing the information the Securities and Exchange Commission requires companies to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual or special stockholder meeting. Issues usually covered in a proxy statement include proposals for new additions to the board of directors, information on directors’ salaries, information on bonus and options plans for directors.
More importantly, a proxy statement discloses any potential conflict of interest between the company and its directors, executives and auditors. Specifically, proxy statements must list any related-party transactions that occurred in the past between the company and its key personnel. Not disclosing conflicts of interest and related party transactions is exactly what the plaintiffs in the XpresSpa are accusing Abbe and friends of doing.
I have previously reported how Abbe is intertwined in this litigation drama with his fellow New York investing buddy Bruce Bernstein, who is president of Rockmore Capital. Bernstein and Abbe have a history of investing along side another small cap financier who has been widely reported on for his alleged leadership role in a pump and dump ring. That man is non other than Barry Honig. One such company is Vringo the predecessor to Form Holdings who is a named defended and the XpresSpa case.
In fact Abbe’s fund Iroquois Capital was named in one of the SEC subpoenas in the Honig Case. The government was looking for communications from Iroquois and one of the companies named for being a pump and dump called MGT Capital. I was first to report on the contents of the SEC subpoena, which was fishing for information to prove this group was trading as undisclosed affiliates and influencing public company CEO’s to get false press release published to drive up the price of a stock.
Surprisingly Iroquois capital, nor its fund managers, were named in the original SEC complaint against Team Honig. The SEC asked the court to file amended complaint, which is due February 6, that could add more names to the Honig enforcement action.
The XpresSpa case is currently in the Summary Judgement phase. This is where the defendants ask the judge to rule on the case without lengthy discovery and depositions being allowed. The former XpresSpa owners will be hoping the judge doesn’t allow summary judgement and the case moves forward to trial. This would force Bernstein and Abbe to have to do depositions and turn over more internal communication via discovery. Keep in mind of a lot the juicy parts of this case are redacted from public filings. A notion I find unfair to public markets and XpresSpa current and future common
PMCB IND is now inactive
FDA rejected PMCB 3 days after it was filed 14 months ago
14 months and PMCBs IND still rejected
My group aways buys at the low and sells at the high money in the bank,PMCB down always make me smile
My group has been buying for a while now. It should be an easy double from here once news starts to flow. Could be a 10 bagger once the IND is filed and completed. I great to be in the fuji islands
PMCB diabetes program doesn't exist it was a total failure just like everything else PCB does
No, there is not massive Shorting of PMCB. The Nasdaq lists 686,975 of "Short Interest" out of 21M shares for the O/S, covering the period up to 15-Sep. That's 3.27% of the shares. One can chalk up most of the 687K "Short Interest" shares to those that hadn't been delivered yet (15-Sep) per the Schedule D stock filing of 01-Sep.
Watch AH - Come Monday we will all be Rich ! !! !
closer to nothing pmcb IND rejected over a year ago and now is inactive
add a bunch at 2.81 and sold at 3.19 can't believe I always hit the high and the lows
one day left for pmcb to hit that 10 dollar mark
getting closer to what everything PMCB is doing has been rejected by the FDA already
I always buy PMCB at the low and sell at the high even while having breakfast with mom
bought 80 thousand shares making 40K a week
Research and development costs 143,613 do you really think they are trying to resubmit the IND, LOL
Since October 30, 2020, there has been no further communication with the FDA regarding the clinical hold.
Pharmacyte Biotech Inc (PMCB)
3.41 -0.18 (-5.01%) 12:28 ET [NASDAQ]
3.41 x 5 3.42 x 40
BARCHART OPINION for Mon, Sep 13th, 2021 Tutorial Alerts Watch Help
Overall Average:
100% SELL
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
0
100
Current Strength
Strong
0
100
Current Direction
Strongest
Barchart Opinion
INDICATOR
Opinion Strength & Direction
Composite Indicator
TrendSpotter
SELL
Short Term Indicators
20 Day Moving Average
SELL
20 - 50 Day MACD Oscillator
SELL
20 - 100 Day MACD Oscillator
SELL
20 - 200 Day MACD Oscillator
SELL
20 - Day Average Volume: 18,474,975 Average: 100% SELL
Medium Term Indicators
50 Day Moving Average
SELL
50 - 100 Day MACD Oscillator
SELL
50 - 150 Day MACD Oscillator
SELL
50 - 200 Day MACD Oscillator
SELL
50 - Day Average Volume: 7,877,769 Average: 100% SELL
Long Term Indicators
100 Day Moving Average
SELL
150 Day Moving Average
SELL
200 Day Moving Average
SELL
100 - 200 Day MACD Oscillator
SELL
100 - Day Average Volume: 3,941,217 Average: 100% SELL
Looking for Barchart Legacy Opinions? Click Here.
Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. After each calculation, the program assigns a buy, sell or hold value for each study, depending on where the price lies in reference to the common interpretation of the study.
Barchart Opinions are not a recommendation to buy or sell a security. Your decision whether or not to make a purchase should be based on your own due diligence and not on any representation we make to you.
Snapshot Opinion
Yesterday
100% SELL Last Week
100% SELL Last Month
100% SELL
Snapshot Opinion is the Barchart Opinion from the prior trading session (yesterday), 1-week ago and 1-month ago.
These statistics give you a sense of the Overall Opinion trend.
Support & Resistance
And McDonald’s has a product pmcb doesn't
everything from this presentation is years old nothing new......where are the results from von Hoff? nowhere they all failed
remember back in the day all the Conferences PMCB said they were attending only to sit in a back room making believe they participated
Sorry ind was rejected by the fda